Cart
sales@molnova.com
HirudonucleodisulfideA
CAS No. 1072789-37-7
HirudonucleodisulfideA( ——— )
Catalog No. M38611 CAS No. 1072789-37-7
Hirudonucleodisulfide A is a heterocyclic compound that can be found in Whitmania pigra. Hirudonucleodisulfide A shows moderately anti-anoxic activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHirudonucleodisulfideA
-
NoteResearch use only, not for human use.
-
Brief DescriptionHirudonucleodisulfide A is a heterocyclic compound that can be found in Whitmania pigra. Hirudonucleodisulfide A shows moderately anti-anoxic activity.
-
DescriptionHirudonucleodisulfide A is a heterocyclic compound that can be found in Whitmania pigra. Hirudonucleodisulfide A shows moderately anti-anoxic activity.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number1072789-37-7
-
Formula Weight310.314
-
Molecular FormulaC10H6N4O4S2
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zheng YF, et, al. Structures of two novel heterocyclics from Whitmania pigra. Planta Med. 2008 Apr;74(5):562-4.?
molnova catalog
related products
-
pTH (2-38) (human)
pTH (2-38) (human)
-
JHU-083
JHU-083, a proagent of 6-diazo-5-oxo-L-norleucine (DON), is an orally active and selective glutaminase antagonist. JHU-083 blocks glutaminase activity in brain CD11b+ cells and experimental cerebral malaria (ECM) resulting in a net decrease of glutamate levels in the animals.
-
Furobufen
Furobufen is a compound with anti-inflammatory and analgesic activity and can be used in the study of arthritis.
